Advisory Board

Steven D. Averbuch, M.D.

Steven D. Averbuch, M.D.

Vice President | Development Oncology and Pharmacodiagnostics for Bristol-Myers Squibb Company


John Fisher, M.D.

John Fisher, M.D.

Chief Executive Officer | Biopsy Sciences


Lili M. Portilla, MPA

Lili M. Portilla, MPA

Director of Strategic Alliances | National Center for Advancing Translational Sciences (NCATS), NIH
Board Member (ex-officio) | University Industry Demonstration Project of the National Archives

Lili Portilla has worked in the area of strategic alliances at the National Institutes of Health (NIH), since 1989. She has extensive expertise in negotiating and developing commercialization strategies for complex, and multi-party collaborations and public private partnerships. Since December of 2011, Ms. Portilla has been serving as the Director of the Office of Strategic Alliances at the National Center for Advancing Translational Sciences (NCATS) at the NIH. NCATS is the newest Center at the NIH focusing on the transformation of the translational science process so that new treatments and cures for disease can be delivered to patients faster. She oversees the Center’s partnership, strategic alliance, and technology transfer functions as well as the Program Director for the NCATS Small Business Innovation Research (SBIR) and Small Technology Transfer Research grant and contract program.

Prior to NCATS, Ms. Portilla was Senior Advisor to the Director of the National Center for Research Resources and as the Director of the National, Heart, Lung and Blood Institute, Office of Technology Transfer and Development. Ms. Portilla has also published several papers on pubic private partnerships. She received a Master’s in Public Administration in 1992 from American University and a Bachelor in Business Administration, double major in both Finance and Spanish Literature in 1986 from Stephen F. Austin State University.


Michael Powell, Ph.D.

Michael Powell, Ph.D.

General Partner | Sofinnova
Adjunct Professor | University of Kansas Department of Pharmaceutical Chemistry


Michael D. Webb

Michael D. Webb

President and Chief Executive Officer | Allegro Diagnostics
Chairman of the Board | Virtify


Thomas Wiggans

Thomas Wiggans

Chief Executive Officer and Director | Dermira, Inc.
Board member | Onyx Pharmaceuticals, Sangamo and Lithera

Last modified: Jan 13, 2016
IAMI Advisory Board duties

The IAMI Advisory Board is composed of six national leaders in medical innovation. The board:

provides insight and advocates for the discovery and development of medical innovations

provides expertise in reviewing and selecting projects

assists in developing a network of potential partners

provides philanthropic development support to target individual, corporate and foundation contributions for the sustainability of IAMI

ID=x4304